Werewolf Therapeutics (HOWL) Q4 2023 Earnings

7MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.59
-0.39
-0.2
0

Details

Expected EPS
-0.424
Actual EPS
-0.33
Surprise EPS
0.09
Surprise Percent
+22.17%

Description

Werewolf Therapeutics (HOWL) has reported earnings of -0.33 per share for Q4 2023.

0 Comments

Share your thoughts